Codiak files for an IPO, again, this time shooting for a nine-digit raise

Codiak Biosciences is filing for an IPO once again, submitting paperwork Wednesday, after backing out of its previous attempt in July 2019 due to unfavorable market conditions. The company is pricing in a new raise of $100 million, up from $86 million in its initial pursuit.